{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T10:38:54Z","timestamp":1791283134475,"version":"4.1.0"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2006,3,1]],"date-time":"2006-03-01T00:00:00Z","timestamp":1141171200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["La Revue de M\u00e9decine Interne"],"published-print":{"date-parts":[[2006,3]]},"DOI":"10.1016\/j.revmed.2005.10.003","type":"journal-article","created":{"date-parts":[[2005,11,9]],"date-time":"2005-11-09T07:15:49Z","timestamp":1131520549000},"page":"227-235","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Cancers et\u00a0infection par\u00a0le\u00a0VIH\u00a0: quelles\u00a0associations\u00a0?"],"prefix":"10.1016","volume":"27","author":[{"given":"F.","family":"Bonnet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.","family":"Morlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.revmed.2005.10.003_bib1","first-page":"1","article-title":"1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults","volume":"41","year":"1992","journal-title":"MMWR"},{"key":"10.1016\/j.revmed.2005.10.003_bib2","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1200\/JCO.1994.12.10.2187","article-title":"Secondary malignancies after bone marrow transplantation in adults","volume":"12","author":"Lowsky","year":"1994","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib3","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1056\/NEJM199703273361301","article-title":"Solid cancers after bone marrow transplantation","volume":"336","author":"Curtis","year":"1997","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib4","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1056\/NEJM199803263381301","article-title":"Declining morbidity and mortality among patients with advanced human immunodeficiency virus infection. HIV Outpatient Study Investigators","volume":"338","author":"Palella","year":"1998","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib5","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1016\/S0140-6736(00)02069-9","article-title":"Survival after introduction of HAART in people with known duration of HIV-1 infection","volume":"355","author":"Collaboration","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.10.003_bib6","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1002\/cncr.20354","article-title":"Malignancies-related causes of death at the era of HAART: The French survey \u2033Mortalit\u00e9 2000\u2033","volume":"101","author":"Bonnet","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib7","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1046\/j.1468-1293.2002.00117.x","article-title":"Causes of death among HIV-infected patients in the era of highly active antiretroviral therapy","volume":"3","author":"Bonnet","year":"2002","journal-title":"HIV Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1023\/A:1010972410865","article-title":"Trends in causes of death in the Aquitaine cohort of HIV-infected patients, 1995-1997","volume":"17","author":"Vandentorren","year":"2001","journal-title":"Eur. J. Epidemiol."},{"key":"10.1016\/j.revmed.2005.10.003_bib9","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/0002-9343(92)90167-A","article-title":"Causes of death in persons with human immunodeficiency virus infection","volume":"93","author":"Stein","year":"1992","journal-title":"Am. J. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib10","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1001\/archinte.1997.00440390055008","article-title":"Causes of death of HIV-infected persons in Ottawa, Ontario, 1984\u20131995","volume":"157","author":"Kravcik","year":"1997","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib11","unstructured":"Lewden C, Salmon D, Morlat P, B\u00e9vilacqua S, Jougla E, Bonnet F, et al. Causes of death among HIV-infected adults living in industrialized countries. A national study over the year 2000. Int. J. Epidemiol. (in press)."},{"key":"10.1016\/j.revmed.2005.10.003_bib12","unstructured":"SC8 Service d'information sur les causes de d\u00e9c\u00e8s. Available from URL: http:\/\/sc8.vesinet.inserm.fr:1080\/ cited 2003-03-04."},{"key":"10.1016\/j.revmed.2005.10.003_bib13","first-page":"373","article-title":"revision of the case definition of acquired immunodeficiency syndrome for national reporting","volume":"34","year":"1985","journal-title":"MMWR"},{"key":"10.1016\/j.revmed.2005.10.003_bib14","first-page":"1823","article-title":"HAART and incidence of cancer in HIV-infected adults","volume":"92","year":"2000","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.revmed.2005.10.003_bib15","doi-asserted-by":"crossref","first-page":"2339","DOI":"10.1182\/blood.V98.8.2339","article-title":"Changes in AIDS-related lymphoma since the era of highly active antiretroviral therapy","volume":"98","author":"Besson","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib16","first-page":"291","article-title":"Acquired immunodeficiency syndrome related lymphomas: clinical aspects","volume":"356","author":"Levine","year":"2000","journal-title":"Semin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib17","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1182\/blood.V98.12.3406","article-title":"Non-Hodgkin lymphoma in HIV-infected patients in the era of highly active antiretroviral therapy","volume":"98","author":"Kirk","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib18","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1097\/00002030-200403050-00012","article-title":"Systemic non-Hodgkin lymphoma in individuals with known dates of HIV seroconversion: incidence and predictors","volume":"18","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib19","doi-asserted-by":"crossref","unstructured":"Bonnet F, Balestre E, Thi\u00e9baut R, Morlat P, Pellegrin JL, Neau D, et al. Factors associated with the occurence of AIDS-related non-Hodgkin lymphoma in the era of HAART. Aquitaine Cohort, France Clin. Inf. Dis.2006; In press.","DOI":"10.1086\/499054"},{"key":"10.1016\/j.revmed.2005.10.003_bib20","first-page":"523","article-title":"Lymphoma genesis in the context of HIV infection","volume":"154","author":"Besson","year":"2003","journal-title":"Ann. Med. Interne (Paris)"},{"key":"10.1016\/j.revmed.2005.10.003_bib21","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1468-1293.2004.00238.x","article-title":"Clinical features and predictors of survival of AIDS-related non-Hodgkin's lymphoma in a population-based case series in Sydney, Australia","volume":"5","author":"Robotin","year":"2004","journal-title":"HIV Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib22","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1002\/(SICI)1097-0142(20000401)88:7<1696::AID-CNCR25>3.0.CO;2-L","article-title":"Prognostic factors after non-Hodgkin lymphoma in patients infected with the human immunodeficiency virus: Aquitaine Cohort, France, 1986\u20131997. Groupe d'\u00e9pid\u00e9miologie clinique du sida en Aquitaine (GECSA)","volume":"88","author":"Thiessard","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib23","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkin's lymphoma since the introduction of highly active antiretroviral therapy","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib24","first-page":"470a","article-title":"CHOP chemotherapy plus rituximab in HIV patients with high-grade lymphoma-Results of an ANRS trial.[Abstract 1824]","volume":"100","author":"Boue","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib25","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1200\/JCO.2001.19.8.2171","article-title":"Chemotherapy for human immunodeficiency virus-associated non-Hodgkin's lymphoma in combination with highly active antiretroviral therapy","volume":"19","author":"Ratner","year":"2001","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib26","doi-asserted-by":"crossref","first-page":"4653","DOI":"10.1182\/blood-2002-11-3589","article-title":"Highly effective treatment of acquired immunodeficiency syndrome-related lymphoma with dose-adjusted EPOCH: impact of antiretroviral therapy suspension and tumor biology","volume":"101","author":"Little","year":"2003","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib27","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood.V99.7.2331","article-title":"High incidence of Kaposi sarcoma-associated herpesvirus-related non-Hodgkin lymphoma in patients with HIV infection and multicentric Castleman disease","volume":"99","author":"Oksenhendler","year":"2002","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib28","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-1293.2004.00204.x","article-title":"Castleman's disease and HIV infection in Australia","volume":"5","author":"Loi","year":"2004","journal-title":"HIV Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib29","doi-asserted-by":"crossref","first-page":"1847","DOI":"10.1097\/00002030-200308150-00015","article-title":"Detection and quantification of Kaposi's sarcoma-associated herpesvirus to predict AIDS-associated Kaposi\u2019s sarcoma","volume":"17","author":"Engels","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib30","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1002\/cncr.20309","article-title":"The changing pattern of Kaposi sarcoma in patients with HIV, 1994\u20132003: the EuroSIDA Study","volume":"100","author":"Mocroft","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib31","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1086\/426078","article-title":"Immune reconstitution inflammatory syndrome associated with Kaposi sarcoma during potent antiretroviral therapy","volume":"39","author":"Connick","year":"2004","journal-title":"Clin. Infect. Dis."},{"key":"10.1016\/j.revmed.2005.10.003_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S1470-2045(03)01192-6","article-title":"Use of HIV protease inhibitors to block Kaposi's sarcoma and tumour growth","volume":"4","author":"Sgadari","year":"2003","journal-title":"Lancet Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib33","doi-asserted-by":"crossref","first-page":"F17","DOI":"10.1097\/00002030-200307250-00001","article-title":"A comparison of regimens based on non-nucleoside reverse transcriptase inhibitors or protease inhibitors in preventing Kaposi's sarcoma","volume":"17","author":"Portsmouth","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib34","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1200\/JCO.2004.08.064","article-title":"Highly active antiretroviral therapy in AIDS-associated Kaposi's sarcoma: implications for the design of therapeutic trials in patients with advanced, symptomatic Kaposi's sarcoma","volume":"22","author":"Krown","year":"2004","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib35","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1016\/S0959-8049(01)00120-4","article-title":"Epidemiology of HIV-associated malignancies in developed and developing countries","volume":"37","author":"Dal Maso","year":"2001","journal-title":"Eur. J. Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1093\/jnci\/djh192","article-title":"Highly active antiretroviral therapy and cervical squamous intraepithelial lesions in human immunodeficiency virus-positive women","volume":"96","author":"Ahdieh-Grant","year":"2004","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.revmed.2005.10.003_bib37","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1097\/00002030-200209060-00013","article-title":"Highly active antiretroviral therapy enhances regression of cervical intraepithelial neoplasia in HIV-seropositive women","volume":"16","author":"Heard","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib38","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1086\/322856","article-title":"Human papillomavirus infection and associated cervical disease in human immunodeficiency virus-infected women: effect of highly active antiretroviral therapy","volume":"184","author":"Lillo","year":"2001","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.revmed.2005.10.003_bib39","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1086\/375783","article-title":"Longitudinal study of cervical squamous intraepithelial lesions in human immunodeficiency virus (HIV)-seropositive and at-risk HIV-seronegative women","volume":"188","author":"Schuman","year":"2003","journal-title":"J. Infect. Dis."},{"key":"10.1016\/j.revmed.2005.10.003_bib40","unstructured":"Recommandations du groupe d'expert. Sous la direction du Pr Jean-Francois Delfraissy. Infections Opportunistes et tumeurs. M\u00e9decine\u2013Science Flammarion, Paris, rapport 2004\u00a0: 227\u201354."},{"key":"10.1016\/j.revmed.2005.10.003_bib41","doi-asserted-by":"crossref","first-page":"3447","DOI":"10.1200\/JCO.2003.01.096","article-title":"Incidence of non-AIDS-defining cancers before and during the highly active antiretroviral therapy era in a cohort of human immunodeficiency virus-infected patients","volume":"21","author":"Herida","year":"2003","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib42","doi-asserted-by":"crossref","first-page":"12667","DOI":"10.1073\/pnas.220203197","article-title":"Zidovudine-didanosine coexposure potentiates DNA incorporation of zidovudine and mutagenesis in human cells","volume":"97","author":"Meng","year":"2000","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.revmed.2005.10.003_bib43","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1182\/blood.V98.2.383","article-title":"The HIV protease inhibitor indinavir inhibits cell-cycle progression in vitro in lymphocytes of HIV-infected and uninfected individuals","volume":"98","author":"Chavan","year":"2001","journal-title":"Blood"},{"key":"10.1016\/j.revmed.2005.10.003_bib44","first-page":"261","article-title":"HIV-1 protease-inhibitor ritonavir modulates susceptibilityto apotptosis of uninfected T-cells","volume":"2","author":"Weichold","year":"1999","journal-title":"J. Hum. Virol."},{"key":"10.1016\/j.revmed.2005.10.003_bib45","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1093\/jnci\/dji072","article-title":"Cancer risk in the Swiss HIV Cohort study: associations with immunodeficiency, smoking, and highly active antiretroviral therapy","volume":"97","author":"Clifford","year":"2005","journal-title":"J. Nat. Cancer Inst."},{"key":"10.1016\/j.revmed.2005.10.003_bib46","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1097\/00002030-199905070-00014","article-title":"Risk of cancer in patients with AIDS","volume":"13","author":"Grulich","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib47","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1001\/jama.285.13.1736","article-title":"Association of cancer with AIDS-related immunosuppression in adults","volume":"285","author":"Frisch","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/j.revmed.2005.10.003_bib48","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1093\/aje\/154.6.544","article-title":"cancer incidence in New York State acquired immunodeficiency syndrome patients","volume":"154","author":"Gallagher","year":"2001","journal-title":"Am. J. Epidemiol."},{"key":"10.1016\/j.revmed.2005.10.003_bib49","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1097\/00002030-200205240-00009","article-title":"Rates of non-AIDS-defining cancers in people with HIV infection before and after AIDS diagnosis","volume":"16","author":"Grulich","year":"2002","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib50","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1097\/00126334-200408010-00013","article-title":"Cancer risk among participants in the women interagency HIV study","volume":"36","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.revmed.2005.10.003_bib51","doi-asserted-by":"crossref","first-page":"744","DOI":"10.7326\/0003-4819-108-5-744","article-title":"Lymphoid neoplasia associated with the acquired immudeficiency syndrome","volume":"108","author":"Knowles","year":"1988","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.7326\/0003-4819-117-4-309","article-title":"Increased incidence of Hodgkin disease in homosexual men with HIV infection","volume":"117","author":"Hessol","year":"1992","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib53","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1200\/JCO.1995.13.7.1758","article-title":"Hodgkin\u2019s disease and HIV infection: clinicopathologic and virologic features of 114 patients from the Italian Cooperative Group on AIDS and Tumors","volume":"13","author":"Tirelli","year":"1995","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.revmed.2005.10.003_bib54","doi-asserted-by":"crossref","first-page":"451","DOI":"10.3109\/10428199509054433","article-title":"HIV associated Hodgkin\u2019s disease: report of 45 cases from the French Registry of HIV Associated Tumors","volume":"16","author":"Levy","year":"1995","journal-title":"Leuk. Lymphoma"},{"key":"10.1016\/j.revmed.2005.10.003_bib55","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1309\/PNVQ0PQGXHVY6L7G","article-title":"HIV-associated Hodgkin Lymphoma","volume":"121","author":"Thompson","year":"2004","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.revmed.2005.10.003_bib56","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/00002030-200301030-00011","article-title":"Improved survival in HIV-related Hodgkin\u2019s lymphoma since the introduction of highly active antiretroviral therapy","volume":"17","author":"Gerard","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib57","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1365-2141.2004.04934.x","article-title":"Strong impact of HAART on survival in patients with HIV-associated Hodgkin\u2019s disease","volume":"125","author":"Hoffmann","year":"2004","journal-title":"Br. J. Haematol."},{"key":"10.1016\/j.revmed.2005.10.003_bib58","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1097\/00005792-200303000-00001","article-title":"The clinical epidemiology of Hodgkin lymphoma in HIV-infected patients in the HAART era","volume":"82","author":"Vilchez","year":"2003","journal-title":"Medicine"},{"key":"10.1016\/j.revmed.2005.10.003_bib59","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1097\/00002030-200302140-00011","article-title":"HIV-related lung cancer in the era of highly active antiretroviral therapy","volume":"17","author":"Bower","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib60","unstructured":"Beck F, Legleye S. Adults and drugs\u00a0: levels of use and recent trends. Trends 2003; 30\u00a0: 1-11. Available at: http:\/\/www.drogues.gouv.fr\/uk\/professionnal\/pdf\/tend30.pdf."},{"key":"10.1016\/j.revmed.2005.10.003_bib61","unstructured":"Patel P, Novak RM, Tong T, Behari P, Moorman A, Palella FJ, et al. Incidence of non-AIDS-defining malignancies in the HIV outpatient study. 11th CROI, San Francisco, 8\u201311 F\u00e9vrier 2004, Abstract 81."},{"key":"10.1016\/j.revmed.2005.10.003_bib62","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1002\/(SICI)1097-0142(20000201)88:3<563::AID-CNCR11>3.0.CO;2-D","article-title":"Lung carcinoma in 36 patients with human immunodeficiency virus infection. The Italian cooperative group on AIDS and tumors","volume":"88","author":"Tirelli","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib63","first-page":"1068","article-title":"Human immunodeficiency virus infection and lung cancer","volume":"84","author":"Alshafie","year":"1997","journal-title":"Br. J. Surg."},{"key":"10.1016\/j.revmed.2005.10.003_bib64","first-page":"6686","article-title":"liver cancer in transgenic mice carrying the HIV tat gene","volume":"51","author":"Vogel","year":"1991","journal-title":"Cancer Res."},{"key":"10.1016\/j.revmed.2005.10.003_bib65","doi-asserted-by":"crossref","first-page":"2285","DOI":"10.1097\/00002030-200411190-00009","article-title":"Hepatocellular carcinoma in HIV-infected patients: epidemiological features, clinical presentation and outcome","volume":"18","author":"Puoti","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib66","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1097\/00002030-200308150-00009","article-title":"Mortality due to hepatitis C-related liver disease in HIV-infected patients in France (Mortavic 2001 study)","volume":"17","author":"Rosenthal","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib67","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1097\/01.aids.0000131335.15301.dd","article-title":"Anal carcinoma: incidence and effect of cumulative infections","volume":"18","author":"Sobhani","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/j.revmed.2005.10.003_bib68","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1097\/00126334-200412150-00004","article-title":"HIV-Associated anal cancer: has highly active antiretroviral therapy reduced the incidence or improved the outcome?","volume":"37","author":"Bower","year":"2004","journal-title":"J. Acquir. Immune Defic. Syndr."},{"key":"10.1016\/j.revmed.2005.10.003_bib69","first-page":"367","article-title":"Anal human papillomavirus DNA screening by Hybrid Capture II in human immunodeficiency virus-positive patients with or without anal intercourse","volume":"13","author":"Drobacheff","year":"2003","journal-title":"Eur. J. Dermatol."},{"key":"10.1016\/j.revmed.2005.10.003_bib70","doi-asserted-by":"crossref","first-page":"453","DOI":"10.7326\/0003-4819-138-6-200303180-00008","article-title":"High prevalence of anal human papillomavirus infection and anal cancer precursors among HIV-infected persons in the absence of anal intercourse","volume":"138","author":"Piketty","year":"2003","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.revmed.2005.10.003_bib71","doi-asserted-by":"crossref","first-page":"1176","DOI":"10.1007\/s10350-004-0910-7","article-title":"Anal carcinomas in HIV-positive patients: high-dose chemoradiotherapy is feasible in the era of highly active antiretroviral therapy","volume":"48","author":"Blazy","year":"2005","journal-title":"Dis. Colon Rectum"},{"key":"10.1016\/j.revmed.2005.10.003_bib72","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(02)07368-3","article-title":"HIV-1 infection and risk of vulvovaginal and perianal condylomata acuminata and intraepithelial neoplasia: a prospective cohort study","volume":"359","author":"Conley","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/j.revmed.2005.10.003_bib73","unstructured":"Preston-Martin S, Seaberg J, Orenstein J. Breast cancer among HIV-infected women: Findings from the women\u2019s Interagency HIV Study (WHIS). Presented at 7th International Conference on Malignancies in AIDS and Other Immunodeficiencies, Bethesda, Maryland, April 28\u201329, 2003."},{"key":"10.1016\/j.revmed.2005.10.003_bib74","first-page":"40","article-title":"Breast cancer and AIDS","volume":"93","author":"Pantanowitz","year":"2001","journal-title":"J. Natl. Med. Assoc."},{"key":"10.1016\/j.revmed.2005.10.003_bib75","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1093\/ajcp\/84.2.144","article-title":"Myelodysplasia in the acquired immune deficiency syndrome","volume":"84","author":"Schneider","year":"1985","journal-title":"Am. J. Clin. Pathol."},{"key":"10.1016\/j.revmed.2005.10.003_bib76","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1046\/j.1365-2141.2001.02661.x","article-title":"Acute myeloid leukaemia in HIV-infected adults: epidemiology, treatment feasibility and outcome","volume":"112","author":"Sutton","year":"2001","journal-title":"Br J Haem"},{"key":"10.1016\/j.revmed.2005.10.003_bib77","first-page":"151","article-title":"Prospective follow-up of monoclonal gammopathies in HIV-infected individuals","volume":"84","author":"Lefrere","year":"1993","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.revmed.2005.10.003_bib78","first-page":"182","article-title":"Isotype of serum monoclonal immunoglobulins in human immunodeficiency virus-infected adults","volume":"74","author":"Briault","year":"1988","journal-title":"Clin. Exp. Immunol."},{"key":"10.1016\/j.revmed.2005.10.003_bib79","first-page":"623","article-title":"Multiple medullary and extramedullary plasmacytomas in an HIV infected female patient. [Article in French]","volume":"21","author":"Delevaux","year":"2000","journal-title":"Rev. Med. Interne"},{"key":"10.1016\/j.revmed.2005.10.003_bib80","first-page":"2005","article-title":"Prevalence of cryoglobulinemia and serological markers of autoimmunity in human immunodeficiency virus infected individuals: a cross-sectional study of 97 patients","volume":"30","author":"Bonnet","year":"2003","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.revmed.2005.10.003_bib81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1258\/002221504322927982","article-title":"Head and neck cancer in patients with human immunodeficiency virus-1 infection: incidence, outcome and association with Epstein-Barr virus","volume":"118","author":"Powles","year":"2004","journal-title":"J. Laryngol. Otol."},{"key":"10.1016\/j.revmed.2005.10.003_bib82","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/sj.bjc.6600451","article-title":"The epidemiology of conjunctival squamous cell carcinoma in Uganda","volume":"87","author":"Newton","year":"2002","journal-title":"Br. J. Cancer"},{"key":"10.1016\/j.revmed.2005.10.003_bib83","doi-asserted-by":"crossref","first-page":"A44","DOI":"10.1097\/00042560-199704010-00155","article-title":"HIV insertional cis-activation of the protooncogene c-fes in AIDS lymphomagenesis","volume":"14","author":"Mack","year":"1997","journal-title":"J Acquir Defic Syndr Hum Retrovirol"},{"key":"10.1016\/j.revmed.2005.10.003_bib84","doi-asserted-by":"crossref","first-page":"351","DOI":"10.3109\/08820139709022692","article-title":"An RGD containing peptide from HIV-1 tat [65\u201380] modulates protooncogene expression in hman bronchoalveolar carcinoma cell line, A549","volume":"26","author":"El-Sohl","year":"1997","journal-title":"Immunol. Invest."},{"key":"10.1016\/j.revmed.2005.10.003_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1089\/jir.1995.15.261","article-title":"Cytokine expression in large cell lymphoma associated with acquired immunodeficiency syndrome","volume":"15","author":"Marsh","year":"1995","journal-title":"J. Interferon Cytokine Res."},{"key":"10.1016\/j.revmed.2005.10.003_bib86","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1126\/science.275.5305.1481","article-title":"Immune hyperactivation of HIV-1-infected cells mediated by Tat and the CD28 pathway","volume":"275","author":"Ott","year":"1997","journal-title":"Science"}],"container-title":["La Revue de M\u00e9decine Interne"],"original-title":[],"language":"fr","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305004273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0248866305004273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:19:30Z","timestamp":1759335570000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0248866305004273"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2006,3]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2006,3]]}},"alternative-id":["S0248866305004273"],"URL":"https:\/\/doi.org\/10.1016\/j.revmed.2005.10.003","relation":{},"ISSN":["0248-8663"],"issn-type":[{"value":"0248-8663","type":"print"}],"subject":[],"published":{"date-parts":[[2006,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cancers et\u00a0infection par\u00a0le\u00a0VIH\u00a0: quelles\u00a0associations\u00a0?","name":"articletitle","label":"Article Title"},{"value":"La Revue de M\u00e9decine Interne","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.revmed.2005.10.003","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2005 Elsevier SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}